Patient adherence to hereditary cancer risk management: a 10-year experience in Singapore
As the Cancer Genetics Service (CGS) in Singapore marks its tenth year, we evaluated adherence to recommended risk management among patients with hereditary cancer syndromes (HCS) to inform service improvements and cost-effectiveness analyses. We conducted a retrospective review of surveillance behaviours, uptake of risk-reducing surgery, and cancers detected during follow-up. Statistical tests were conducted to assess association between patient characteristics and adherence behaviours. There were 729 patients with HCS, largely comprised of females (79.7%), Chinese (73.5%), with a syndrome-related manifestation prior to testing (74.1%) and a family history of cancer (90.9%). Overall, 66.4% of our patients were fully adherent (FA) to recommended risk management; 10.4% were highly adherent (HA), 14.4% were lowly adherent (LA) and 8.8% were non-adherent (NA). Overall adherence was high across most HCS cohorts. Higher adherence was observed among individuals with high risk HCS, including Hereditary Breast Ovarian Cancer Syndrome, Lynch Syndrome and Familial Adenomatous Polyposis. High adherence of Neurofibromatosis Type 1 patients suggests that access to coordinated, multidisciplinary services may facilitate adherence. As healthcare systems move toward precision public health, strengthening risk communication and investing in multidisciplinary care models should be prioritised to support adherence to recommended risk-management strategies, particularly in high-risk populations.
Authors
- Zewen Zhang
- Sowmya Jonnagadla (ORCID: https://orcid.org/0000-0002-5789-5082)
- Diana Ishak
- Shun Zi Liong
- CHIANG JIANBANG
- Joanne Ngeow
- Shao-Tzu Li
- Jeanette Yuen
Institutions
- Nanyang Technological University (SG)
- National Cancer Centre Singapore (SG)
Publication Details
- Journal
- npj Genomic Medicine
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1038/s41525-026-00633-5
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Centre of Singapore
- Singapore Cancer Society
- National Research Foundation
- Precision Health Research, Singapore
- National Medical Research Council